5 Drug Manufacturers—Specialty & Generic Stocks Moving In Tuesday's After-Market Session

Gainers

• Assertio Therapeutics, Inc. ASRT stock moved upwards by 3.1% to $1.34 during Tuesday's after-market session.

Losers

• Durect, Inc. DRRX shares fell 4.7% to $2.01 during Tuesday's after-market session. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.

• Lannett, Inc. LCI stock decreased by 4.4% to $9.07.

• Amneal Pharmaceuticals, Inc. AMRX stock decreased by 4.1% to $5.11. The most recent rating by RBC Capital, on January 02, is at Sector Perform, with a price target of $4.00.

• Solid Biosciences, Inc. SLDB shares plummeted 3.7% to $3.61. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.